Telix Pharmaceuticals Limited, an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has today announced the establishment Telix Pharmaceuticals (Japan) Ltd and appointment of the first two members of the Japanese leadership team. Telix Japan is wholly owned operating subsidiary of Telix Pharmaceuticals Limited.…